These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20361492)

  • 1. [Platelet abnormalities in type 2 diabetes mellitus].
    Matadamas-Zárate C; Hernández-Jerónimo J; Pérez-Campos E; Majluf-Cruz A
    Arch Cardiol Mex; 2009 Dec; 79 Suppl 2():102-8. PubMed ID: 20361492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review.
    El Haouari M; Rosado JA
    Blood Cells Mol Dis; 2008; 41(1):119-23. PubMed ID: 18387322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy in type 2 diabetes mellitus.
    Angiolillo DJ
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):124-31. PubMed ID: 17940430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes, coagulation and vascular events].
    Nenci GG; Paliani U
    Recenti Prog Med; 2000 Feb; 91(2):86-90. PubMed ID: 10748654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus as a prothrombotic condition.
    Grant PJ
    J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-leukocyte-cross-talk in diabetes mellitus.
    Tschoepe D; Rauch U; Schwippert B
    Horm Metab Res; 1997 Dec; 29(12):631-5. PubMed ID: 9497901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone.
    Randriamboavonjy V; Pistrosch F; Bölck B; Schwinger RH; Dixit M; Badenhoop K; Cohen RA; Busse R; Fleming I
    Circulation; 2008 Jan; 117(1):52-60. PubMed ID: 18071073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia.
    Massi-Benedetti M; Federici MO
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S120-3. PubMed ID: 10522835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet nitric oxide production and IR: relation with obesity and hypertriglyceridemia.
    Vignini A; Nanetti L; Moroni C; Testa R; Sirolla C; Marra M; Cenerelli S; Gregori A; Fumelli D; Olivieri F; Mazzanti L; Rabini RA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):553-8. PubMed ID: 18155481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
    Rask-Madsen C; King GL
    Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Haemocoagulation and renal insufficiency, haemocoagulation and type 2 diabetes mellitus].
    Malý J; Simkovic M; Pecka M
    Vnitr Lek; 2008 May; 54(5):452-6. PubMed ID: 18630625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
    Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
    Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus and thrombosis.
    Vazzana N; Ranalli P; Cuccurullo C; Davì G
    Thromb Res; 2012 Mar; 129(3):371-7. PubMed ID: 22197180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
    Farkas K; Sármán B; Jermendy G; Somogyi A
    Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinnamtannin B-1 from bay wood reduces abnormal intracellular Ca2+ homeostasis and platelet hyperaggregability in type 2 diabetes mellitus patients.
    Bouaziz A; Salido S; Linares-Palomino PJ; Sanchez A; Altarejos J; Bartegi A; Salido GM; Rosado JA
    Arch Biochem Biophys; 2007 Jan; 457(2):235-42. PubMed ID: 17118329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.